Handa Pharmaceuticals, Inc. (TPEX:6620)
Taiwan
· Delayed Price · Currency is TWD 77.80
-2.00 (-2.51%)
Mar 9, 2026, 1:30 PM CST
Handa Pharmaceuticals Market Cap
Handa Pharmaceuticals has a market cap or net worth of 12.24 billion as of March 9, 2026. Its market cap has increased by 6.89% in one year.
Market Cap
12.24B
Enterprise Value
9.67B
Revenue
1.62B
Ranking
n/a
PE Ratio
17.17
Stock Price
77.80
Market Cap Chart
Since December 28, 2016, Handa Pharmaceuticals's market cap has increased from 8.32B to 12.24B, an increase of 47.14%. That is a compound annual growth rate of 4.29%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alar Pharmaceuticals | 12.83B |
| Foresee Pharmaceuticals | 12.86B |
| Standard Chemical & Pharmaceutical | 11.54B |
| YungShin Global Holding | 14.46B |
| Synmosa Biopharma | 15.92B |
| ScinoPharm Taiwan | 17.12B |
| Grape King Bio | 17.85B |
| TTY Biopharm Company | 20.74B |